Efficacy and safety of immune checkpoint inhibitors combined with neoadjuvant chemotherapy in the treatment of early triple-negative breast cancer: a meta-analysis
|更新时间:2026-01-24
|
Efficacy and safety of immune checkpoint inhibitors combined with neoadjuvant chemotherapy in the treatment of early triple-negative breast cancer: a meta-analysis
“The latest research shows that immunocheckpoint inhibitor combined with neoadjuvant chemotherapy significantly improves the survival period of early triple negative breast cancer patients, but increases the risk of serious adverse events.”
YANG Zhixuan,LI Shuo,WANG Peiyuan,et al.Efficacy and safety of immune checkpoint inhibitors combined with neoadjuvant chemotherapy in the treatment of early triple-negative breast cancer: a meta-analysis[J].ZHONGGUO YAOFANG,2026,37(02):238-243.
YANG Zhixuan,LI Shuo,WANG Peiyuan,et al.Efficacy and safety of immune checkpoint inhibitors combined with neoadjuvant chemotherapy in the treatment of early triple-negative breast cancer: a meta-analysis[J].ZHONGGUO YAOFANG,2026,37(02):238-243. DOI: 10.6039/j.issn.1001-0408.2026.02.18.
Efficacy and safety of immune checkpoint inhibitors combined with neoadjuvant chemotherapy in the treatment of early triple-negative breast cancer: a meta-analysis
Meta-analysis of the efficacy and safety total glucosides of paeonia in the treatment of systemic lupus erythematosus
Meta-analysis of efficacy and safety of intranasal corticosteroids combined with oral H1-antihistamine in the treatment of allergic rhinitis
The effects of evolocumab combined with atorvastatin on post-PCI efficacy and coronary microcirculation in patients with acute ST-segment elevation myocardial infarction
Clinical observation of Shouhui tongbian capsule combined with linaclotide in the treatment of constipation-predominant irritable bowel syndrome
Efficacy and safety comparison of dupilumab versus thalidomide in the treatment of refractory prurigo nodularis in adults
Related Author
HAO Xiangyan
LENG Jiahui
LIU Zhengqi
WANG Xinchang
HUANG Cong
LI Xiaopeng
LING Yi
CHEN Huajiao
Related Institution
Graduate School, Guizhou University of Traditional Chinese Medicine
Dept. of Rheumatology and Immunology, the Second Affiliated Hospital of Guizhou University of TCM
Dept. of Rheumatology and Immunology, the Second Affiliated Hospital of Zhejiang University of TCM
Scientific Research Department, the Second Affiliated Hospital of Zhejiang University of TCM
Dept. of Otorhinolaryngology-Head and Neck Surgery, Chongqing University Fuling Hospital